Journal of Cardiac Failure
Volume 16, Issue 11 , Pages 901-910 , November 2010

Critical Role for Death-Receptor Mediated Apoptotic Signaling in Viral Myocarditis

  • Roberta L. Debiasi, MD

      Affiliations

    • Department of Pediatrics, Children's National Medical Center and George Washington University School of Medicine, Washington, DC
    • Corresponding Author InformationReprint requests: Roberta L. DeBiasi, MD, Associate Professor of Pediatrics, George Washington University School of Medicine, Children's National Medical Center/Children's Research Institute, 111 Michigan Ave NW/Pediatric Infectious Diseases WW3.5, Washington, DC 20010. Tel: (202) 476-5051; Fax: (202) 476-3850.
    • ,
  • Bridget A. Robinson, MS

      Affiliations

    • Vaccine and Gene Therapy Institute, Oregon Health and Science University, Molecular Microbiology and Immunology Department, Portland, OR
    • ,
  • J. Smith Leser, BS

      Affiliations

    • Department of Neurology, University of Colorado Denver, Aurora, CO
    • ,
  • R. Dale Brown, PhD

      Affiliations

    • Department of Pediatrics, University of Colorado Denver, Aurora, CO
    • ,
  • Carlin S. Long, MD

      Affiliations

    • Department of Medicine, University of Colorado Denver, Aurora, CO
    • ,
  • Penny Clarke, PhD

      Affiliations

    • Department of Neurology, University of Colorado Denver, Aurora, CO

Received 11 March 2010 ,Accepted 28 May 2010.

References 

  1. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000;343:1388–1398
  2. Miyamoto SD, DeBiasis RL, Long CS. Novel therapeutic targets in viral myocarditis. Future Virol. 2008;3:373–381
  3. Neuss M, Crow MT, Chesley A, Lakatta EG. Apoptosis in cardiac disease–what is it–how does it occur. Cardiovasc Drugs Ther. 2001;15:507–523
  4. Bishopric NH, Andreka P, Slepak T, Webster KA. Molecular mechanisms of apoptosis in the cardiac myocyte. Curr Opin Pharmacol. 2001;1:141–150
  5. James TN. Apoptosis in cardiac disease. Am J Med. 1999;107:606–620
  6. Bueno AC, Cornick-Seahorn J, Seahorn TL, Hosgood G, Moore RM. Cardiopulmonary and sedative effects of intravenous administration of low doses of medetomidine and xylazine to adult horses. Am J Vet Res. 1999;60:1371–1376
  7. De Windt LJ, Lim HW, Taigen T, Wencker D, Condorelli G, Dorn GW, et al. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: an apoptosis-independent model of dilated heart failure. Circ Res. 2000;86:255–263
  8. Shizukuda Y, Buttrick PM, Geenen DL, Borczuk AC, Kitsis RN, Sonnenblick EH. Beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol. 1998;275:H961–H968
  9. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, et al. Apoptosis in the failing human heart. N Engl J Med. 1997;336:1131–1141
  10. Bialik S, Geenen DL, Sasson IE, Cheng R, Horner JW, Evans SM, et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest. 1997;100:1363–1372
  11. Miao W, Luo Z, Kitsis RN, Walsh K. Intracoronary, adenovirus-mediated Akt gene transfer in heart limits infarct size following ischemia-reperfusion injury in vivo. J Mol Cell Cardiol. 2000;32:2397–2402
  12. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 2000;101:660–667
  13. Shen Y, Shenk TE. Viruses and apoptosis. Curr Opin Genet Dev. 1995;5:105–111
  14. DeBiasi RL, Edelstein CL, Sherry B, Tyler KL. Calpain inhibition protects against virus-induced apoptotic myocardial injury. J Virol. 2001;75:351–361
  15. DeBiasi RL, Clarke P, Meintzer S, Jotte R, Kleinschmidt-Demasters BK, Johnson GL, et al. Reovirus-induced alteration in expression of apoptosis and DNA repair genes with potential roles in viral pathogenesis. J Virol. 2003;77:8934–8947
  16. Alter P, Jobmann M, Meyer E, Pankuweit S, Maisch B. Apoptosis in myocarditis and dilated cardiomyopathy: does enterovirus genome persistence protect from apoptosis? An endomyocardial biopsy study. Cardiovasc Pathol. 2001;10:229–234
  17. Yang D, Yu J, Luo Z, Carthy CM, Wilson JE, Liu Z, et al. Viral myocarditis: identification of five differentially expressed genes in coxsackievirus B3-infected mouse heart. Circ Res. 1999;84:704–712
  18. Colston JT, Chandrasekar B, Freeman GL. Expression of apoptosis-related proteins in experimental coxsackievirus myocarditis. Cardiovasc Res. 1998;38:158–168
  19. Sherry B, Schoen FJ, Wenske E, Fields BN. Derivation and characterization of an efficiently myocarditic reovirus variant. J Virol. 1989;63:4840–4849
  20. Sherry B. Pathogenesis of reovirus myocarditis. Curr Top Microbiol Immunol. 1998;233:51–66
  21. Sherry B, Baty CJ, Blum MA. Reovirus-induced acute myocarditis in mice correlates with viral RNA synthesis rather than generation of infectious virus in cardiac myocytes. J Virol. 1996;70:6709–6715
  22. DeBiasi RL, Robinson BA, Sherry B, Bouchard R, Brown RD, Rizeq M, et al. Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol. 2004;78:11040–11050
  23. Clarke P, Tyler KL. Apoptosis in animal models of virus-induced disease. Nat Rev Microbiol. 2009;7:144–155
  24. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998;281:1305–1308
  25. Itoh N, Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem. 1993;268:10932–10937
  26. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 1993;74:845–853
  27. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity. 1998;9:267–276
  28. Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science. 1998;279:1954–1958
  29. Zhang J, Cado D, Chen A, Kabra NH, Winoto A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature. 1998;392:296–300
  30. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309–1312
  31. Chipuk JE, Green DR. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?. Trends Cell Biol. 2008;18:157–164
  32. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999;13:1899–1911
  33. Clarke P, Beckham JD, Leser JS, Hoyt CC, Tyler KL. Fas-mediated apoptotic signaling in the mouse brain following reovirus infection. J Virol. 2009;83:6161–6170
  34. Kominsky DJ, Bickel RJ, Tyler KL. Reovirus-induced apoptosis requires both death receptor- and mitochondrial-mediated caspase-dependent pathways of cell death. Cell Death Differ. 2002;9:926–933
  35. Richardson-Burns SM, Kominsky DJ, Tyler KL. Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors. J Neurovirol. 2002;8:365–380
  36. Clarke P, Meintzer SM, Gibson S, Widmann C, Garrington TP, Johnson GL, et al. Reovirus-induced apoptosis is mediated by TRAIL. J Virol. 2000;74:8135–8139
  37. Kominsky DJ, Bickel RJ, Tyler KL. Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels. J Virol. 2002;76:11414–11424
  38. Rodgers SE, Barton ES, Oberhaus SM, Pike B, Gibson CA, Tyler KL, et al. Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J Virol. 1997;71:2540–2546
  39. Tyler KL, Bronson RT, Byers KB, Fields B. Molecular basis of viral neurotropism: experimental reovirus infection. Neurology. 1985;35:88–92
  40. Tyler KL, Squier MK, Rodgers SE, Schneider BE, Oberhaus SM, Grdina TA, et al. Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein sigma 1. J Virol. 1995;69:6972–6979
  41. Clarke P, Meintzer SM, Spalding AC, Johnson GL, Tyler KL. Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection. Oncogene. 2001;20:6910–6919
  42. Miyamoto SD, Brown RD, Robinson BA, Tyler KL, long CS, Debiasi RL. Cardiac cell-specific apoptotic and cytokine responses to virus infection: determinants of myocarditic phenotype. J Card Fail. 2009;15:529–539
  43. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem. 2001;276:20633–20640
  44. Clarke P, DeBiasi RL, Meintzer SM, Robinson BA, Tyler KL. Inhibition of NF-κB activity and cFLIP expression contribute to viral-induced apoptosis. Apoptosis. 2005;10:513–524
  45. Clarke P, Tyler KL. Down-regulation of cFLIP following reovirus infection sensitizes human ovarian cancer cells to TRAIL-induced apoptosis. Apoptosis. 2007;12:211–223
  46. Wu XQ, Li YH, Zhu X, Wu MW, Hu SM. [Expression of Fas protein in myocardiac tissue of viral myocarditis and dilated cardiomyopathy]. Fa Yi Xue Za Zhi. 2008;24:414–416
  47. Toyozaki T, Hiroe M, Saito T, Iijima Y, Takano H, Hiroshima K, et al. Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin, and in healthy volunteers. Am J Cardiol. 1998;81:798–800
  48. Fuse K, Kodama M, Okura Y, Ito M, Hirono S, Kato K, et al. Predictors of disease course in patients with acute myocarditis. Circulation. 2000;102:2829–2835
  49. Seko Y, Kayagaki N, Seino K, Yagita H, Okumura K, Nagai R. Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3. J Am Coll Cardiol. 2002;39:1399–1403
  50. Huber SA. T cells expressing the gamma delta T cell receptor induce apoptosis in cardiac myocytes. Cardiovasc Res. 2000;45:579–587
  51. Wang XF, Zhou L, Nan CH. [Effect of radix bupleuri extract on cardiomyocyte apoptosis related genes expression in mouse infected with coxsackie virus B3m]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005;25:925–928
  52. Chang H, Han B, Han XZ. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice]. Zhonghua Er Ke Za Zhi. 2005;43:920–924
  53. Nie YJ, Huang XY, Wang SH. [Effect of IFN-lambda2 on apoptotic protein in the myocardium in mice with viral myocarditis]. Zhongguo Dang Dai Er Ke Za Zhi. 2009;11:296–300
  54. Kyto V, Lapatto R, Lakkisto P, Saraste A, Voipio-Pulkki LM, Vuorinen T, et al. Glutathione depletion and cardiomyocyte apoptosis in viral myocarditis. Eur J Clin Invest. 2004;34:167–175

 Supported by grants (P.C.): NS050138 (RO1) and NS051403 (RO1) from the National Institute of Health, VA Merit funding and an Academic Enrichment Fund (School of Medicine, University of Colorado Denver); (R.D.): AI052261 (K08) from the National Institutes of Health, and a Research Award Council award (Children's Research Institute, CNMC); (D.B.): Research Scholar Award from the Children's Hospital, Denver, CO; (C.L.): Grant HL79160 from NIH.

 See page 909 for disclosure information.

PII: S1071-9164(10)00254-X

doi: 10.1016/j.cardfail.2010.05.030

Journal of Cardiac Failure
Volume 16, Issue 11 , Pages 901-910 , November 2010

Article Tools

* Image Usage & Resolution